©The Author(s) 2025.
World J Orthop. Dec 18, 2025; 16(12): 110291
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.110291
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.110291
Table 1 Patient demographic characteristics
| Demographics | Value |
| Gender (male/female) | 45/28 |
| Age (years) | 39.10 ± 11.22 (21-67) |
| BMI (kg/m2) | 23.00 ± 3.48 |
| Follow up time (month) | 53.58 ± 26.80 (18-129) |
| THA (hips) | 7 |
| Hip preservation surgery (hips) | 4 |
| Etiology (hips) | |
| Steroid | 59 |
| Alcohol | 22 |
| Trauma | 13 |
| Idiopathic | 25 |
| ARCO stage (hips) | |
| Stage I | 2 |
| Stage II | 41 |
| Stage IIIa | 59 |
| Stage IIIb | 17 |
| JIC classification (hips) | |
| Type A | 12 |
| Type B | 26 |
| Type C1 | 54 |
| Type C2 | 27 |
| Lesion size (hips) | |
| < 15% | 26 |
| 15%-30% | 37 |
| > 30% | 56 |
| Collapse degree (hips) | |
| ≤ 2 mm | 102 |
| > 2 mm | 17 |
- Citation: Chen WH, Zhuang C, Guo WJ, Guo WX, He W, Pan Y. Outcomes of the conservative hip preservation treatment in patients with osteonecrosis of the femoral head: With 4-year follow-up. World J Orthop 2025; 16(12): 110291
- URL: https://www.wjgnet.com/2218-5836/full/v16/i12/110291.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i12.110291